Can data make a medicine? – with Patrick Vallance of GSK
Gait Up is proud to support GSK’s Dr. Patrick Vallance, President of R&D, in his 26 May discourse at The Royal Institution in London. Patrick’s discourse Can data make a medicine?, explores how real-time data and open-source information can improve the world of medicine.
You can access the full discourse published on YouTube by The Royal Institution here: https://youtu.be/zvJdnLkJH6Q
In the opening scene, Dr. Vallance enters the stage wearing Physilog 5, running a special embedded version of Gait Up’s industry leading algorithms, to compute temporal gait events as they occur. As he strides about the theater, his gait phases are streamed to the projector screen and he says, “That’s me walking around. Not just saying how many steps I do, but looking at my gait, looking at how I walk, looking at the shape of the way in which I make an arc as I walk.”
Later in his talk (28:20), Dr. Vallance refers back to the opening scene to tell a story about drug development by GSK for Muscular Dystrophy. In the story, GSK needed to run a clinical study to see if their new drug worked, by measuring how far children with Muscular Dystrophy were able to walk during the common six minute walk test (6MWT).
What GSK found, is that the children’s walking distance was influenced by factors other than the new drug and Muscular Dystrophy. For example, their mood, or how they felt about their parents, or the doctor, on that particular day. On it’s own, the 6MWT could not be used as an effective study endpoint.
In the words of Dr. Vallance, “We need to be able to measure the sorts of things I’m talking about, the sorts of things like gait, not just can you walk up and down, but actually has your gait changed as you’re doing it.. and of course you can imagine that’s true following stroke, it’s following all sorts of neurological diseases. So, this ability to monitor much more than we currently do, is going to be instrumental in terms of trying to work out new treatments for difficult diseases.”
Thank you Dr. Vallance, for showcasing how companies like GSK can use Gait Up technology to improve healthcare and the world of medicine.
Gait Up is committed to building the most accurate wearable motion sensors to solve pressing needs in healthcare, sports and virtual reality. To work in such diverse industries, Gait Up takes the role of innovator and partner to leading companies and professionals in each vertical where we have a presence. With deep roots in clinical research, Gait Up founders are the pioneers of wearable motion science. Gait Up, make sense of motion.
The Royal Institution is an independent charity dedicated to connecting people with the world of science. Founded in 1799 by a group of 58 wealthy individuals, the Ri has been home to eminent scientists whose discoveries have shaped the modern world: Humphry Davy’s miners’ safety lamp; Michael Faraday’s work on electromagnetic induction; John Tyndall’s discovery of the greenhouse effect. In only three years since it’s launch, the digital Ri Channel has had over 16 million views and each talk on average is viewed over 70,000 times.
GSK is a global healthcare company that takes on some of the world’s biggest healthcare challenges. By delivering sustainable business, GSK provides health benefits to patients and consumers, improved shareholder returns as well as supporting wider society. GSK has three world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. GSK is committed to widening access to it’s products, so more people can benefit, no matter where they live in the world or what they can afford to pay.